Antibiotic resistance is already one of the biggest health challenges facing the world today. Every year, infections that no longer respond well to treatment are linked to more than a…
Good day here from STAT’s London outpost, with Andrew Joseph filling in for Mr. Pharmalot. Maybe the less said about the U.S. World Cup match the better, though watching it…
MTI Viewpoints Insights shared by industry relative to healthcare and the advancement of medical technology. Jaimon Jose, senior director of engineering and compliance at CharmHealth, is a software architect and…
Introduction: PMS Is Working—But Not Where It Matters Most Post-market surveillance (PMS) systems across the medical device industry have never been more mature. Organizations are capturing complaints, monitoring adverse events,…
Drugmakers provide financial assistance to help patients afford increasingly expensive medications. But some insurers do not count those payments toward a plan’s deductible or out-of-pocket maximum and make patients pay…
Thousands of people who had a Medicare drug plan with zero-dollar premiums last year got small premium increases this year — and didn’t know it. They were dropped from their…
Divorce is a tool, not a weapon, says Karen McNenny, author of a new book on the subject. She explains how to end a marriage while protecting your family and…
Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder, the companies announced Monday. Through the deal, Vertex will pick up Crinetics’…
In some towns in India, people working for a non profit approach people who appear to have trouble reading small print to get them hooked up with glasses.
California’s next governor will face tough decisions on a highly controversial piece of healthcare policy: what to do about health coverage for the more than 1.4 million low-income residents without…